Kun Wang

12.2k total citations · 4 hit papers
147 papers, 9.3k citations indexed

About

Kun Wang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kun Wang has authored 147 papers receiving a total of 9.3k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Molecular Biology, 88 papers in Cancer Research and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kun Wang's work include MicroRNA in disease regulation (69 papers), Circular RNAs in diseases (61 papers) and Cancer-related molecular mechanisms research (43 papers). Kun Wang is often cited by papers focused on MicroRNA in disease regulation (69 papers), Circular RNAs in diseases (61 papers) and Cancer-related molecular mechanisms research (43 papers). Kun Wang collaborates with scholars based in China, United States and Canada. Kun Wang's co-authors include Peifeng Li, Bo Long, Feng Shao, Hanzi Sun, Dacheng Wang, Wang Liu, Jingjin Ding, Qi Sun, Jianjin Shi and Lu‐Yu Zhou and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Kun Wang

137 papers receiving 9.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pore-forming activity and structural autoinhibition of the gasdermin family

2016 2.1k citations Kun Wang et al. profile →
A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223

2016 738 citations Kun Wang, Fang Liu et al. profile →
miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1

2010 509 citations Kun Wang, Peifeng Li et al. profile →
The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489

2014 465 citations Kun Wang, Fang Liu et al. Circulation Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kun Wang China	44	7.8k	4.6k	1.2k	716	662	147	9.3k
Anton Jan van Zonneveld Netherlands	57	5.0k 0.6×	3.1k 0.7×	1.1k 1.0×	1.1k 1.5×	629 1.0×	211	10.6k
Anton J.G. Horrevoets Netherlands	43	4.2k 0.5×	1.8k 0.4×	1.3k 1.1×	1.1k 1.6×	431 0.7×	106	7.1k
Zhen Chen China	42	4.0k 0.5×	1.8k 0.4×	861 0.7×	411 0.6×	524 0.8×	241	6.3k
Bin Zhang China	43	6.3k 0.8×	3.4k 0.7×	1.4k 1.2×	143 0.2×	713 1.1×	177	9.1k
Reinier A. Boon Germany	40	5.8k 0.7×	4.2k 0.9×	764 0.7×	983 1.4×	319 0.5×	98	7.7k
Shusheng Wang United States	40	5.9k 0.8×	3.5k 0.8×	717 0.6×	369 0.5×	343 0.5×	108	8.3k
Min Xie United States	40	4.8k 0.6×	1.5k 0.3×	905 0.8×	1.2k 1.6×	789 1.2×	125	7.7k
Eva van Rooij Netherlands	46	10.9k 1.4×	7.9k 1.7×	559 0.5×	2.7k 3.7×	556 0.8×	92	13.9k
Qiang Wang China	41	4.9k 0.6×	3.0k 0.6×	476 0.4×	258 0.4×	732 1.1×	287	7.2k
Sarah J. George United Kingdom	52	3.0k 0.4×	2.3k 0.5×	1.3k 1.1×	1.1k 1.6×	481 0.7×	175	7.8k

Countries citing papers authored by Kun Wang

Since Specialization

Citations

This map shows the geographic impact of Kun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Wang more than expected).

Fields of papers citing papers by Kun Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Wang. The network helps show where Kun Wang may publish in the future.

Co-authorship network of co-authors of Kun Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kun Wang. A scholar is included among the top collaborators of Kun Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kun Wang. Kun Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Dingchao, Huaizhen Liang, Bide Tong, et al.. (2025). DDX1 methylation mediated MATR3 splicing regulates intervertebral disc degeneration by initiating chromatin reprogramming. Nature Communications. 16(1). 6153–6153. 1 indexed citations

Li, Yinghui, Qian Meng, Peiyu Li, et al.. (2025). Harnessing miRNA therapeutics: a novel approach to combat heart and brain infarctions in atherosclerosis. Cell Death Discovery. 11(1). 482–482.

Liu, Zhao, Yuan Gao, Kun Wang, et al.. (2025). Whole transcriptome sequencing-based identification and functional prediction of salt-tolerant-related circular RNAs in ZM-4 (Malus zumi). International Journal of Biological Macromolecules. 306(Pt 4). 141572–141572.

Zhao, Yan, Kai Wang, Chun Zhao, et al.. (2024). The function of tRNA-derived small RNAs in cardiovascular diseases. Molecular Therapy — Nucleic Acids. 35(1). 102114–102114. 8 indexed citations

Wang, Kun, Chun‐yang Zhang, Rui Wang, et al.. (2024). Cowpea lipid transfer protein 1 regulates plant defense by inhibiting the cysteine protease of cowpea mosaic virus. Proceedings of the National Academy of Sciences. 121(35). e2403424121–e2403424121. 7 indexed citations

Li, Bo, et al.. (2024). Recent advances of PIWI‐interacting RNA in cardiovascular diseases. Clinical and Translational Medicine. 14(8). 9 indexed citations

Wang, Kai, Cuiyun Liu, Bo Li, et al.. (2024). The function and therapeutic potential of transfer RNA-derived small RNAs in cardiovascular diseases: A review. Pharmacological Research. 206. 107279–107279. 6 indexed citations

Ju, Jie, Kai Wang, Fang Liu, et al.. (2024). Crotonylation of NAE1 Modulates Cardiac Hypertrophy via Gelsolin Neddylation. Circulation Research. 135(8). 806–821. 9 indexed citations

Wang, Ruiquan, Xinzhe Chen, Xinmin Li, & Kun Wang. (2023). Molecular therapy of cardiac ischemia–reperfusion injury based on mitochondria and ferroptosis. Journal of Molecular Medicine. 101(9). 1059–1071. 14 indexed citations

10.

Wang, Zhongyu, et al.. (2023). Advances in Point-of-Care Testing of microRNAs Based on Portable Instruments and Visual Detection. Biosensors. 13(7). 747–747. 19 indexed citations

11.

Wang, Kun, et al.. (2023). The ufmylation modification of ribosomal protein L10 in the development of pancreatic adenocarcinoma. Cell Death and Disease. 14(6). 350–350. 20 indexed citations

12.

Wang, Kai, Fuhai Li, Lu‐Yu Zhou, et al.. (2023). HNEAP Regulates Necroptosis of Cardiomyocytes by Suppressing the m⁵C Methylation of Atf7 mRNA. Advanced Science. 10(34). e2304329–e2304329. 19 indexed citations

13.

Niu, Kongyan, Jinyang Zhang, Dean Li, et al.. (2022). ONE-seq: epitranscriptome and gene-specific profiling of NAD-capped RNA. Nucleic Acids Research. 51(2). e12–e12. 12 indexed citations

14.

Wang, Kai, Xinzhe Chen, Yunhong Wang, et al.. (2022). Emerging roles of ferroptosis in cardiovascular diseases. Cell Death Discovery. 8(1). 394–394. 77 indexed citations

15.

Li, Gaocai, Rongjin Luo, Weifeng Zhang, et al.. (2022). m6A hypomethylation of DNMT3B regulated by ALKBH5 promotes intervertebral disc degeneration via E4F1 deficiency. Clinical and Translational Medicine. 12(3). e765–e765. 50 indexed citations

16.

Chen, Xinzhe, et al.. (2022). Pyroptosis: Role and Mechanisms in Cardiovascular Disease. Frontiers in Cardiovascular Medicine. 9. 897815–897815. 43 indexed citations

17.

Shan, Peipei, Feifei Yang, Hongzhao Qi, et al.. (2021). Alteration of MDM2 by the Small Molecule YF438 Exerts Antitumor Effects in Triple-Negative Breast Cancer. Cancer Research. 81(15). 4027–4040. 41 indexed citations

18.

Ju, Jie, Yanan Song, Xinzhe Chen, et al.. (2021). circRNA is a potential target for cardiovascular diseases treatment. Molecular and Cellular Biochemistry. 477(2). 417–430. 40 indexed citations

19.

Zhang, Meiling, et al.. (2020). Epitranscriptome analysis of COVID-19 prevention and control. 33. 1 indexed citations

20.

Wang, Kun, Zhifan Jia, Anling Zhang, et al.. (2011). Inhibitory effects of knocking down microRNA-19a and microRNA-19b on glioma cell growth in vitro. Chinese Journal of Neuromedicine. 10(4). 365–368. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact